RBF Capital LLC held its position in Sanofi (NYSE:SNY) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 50,606 shares of the company’s stock at the end of the first quarter. RBF Capital LLC’s holdings in Sanofi were worth $2,290,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Weik Investment Services Inc. boosted its stake in shares of Sanofi by 0.9% in the first quarter. Weik Investment Services Inc. now owns 5,895 shares of the company’s stock worth $267,000 after buying an additional 50 shares during the period. Argent Trust Co boosted its stake in shares of Sanofi by 1.4% in the first quarter. Argent Trust Co now owns 8,015 shares of the company’s stock worth $363,000 after buying an additional 113 shares during the period. Huntington National Bank boosted its stake in shares of Sanofi by 3.4% in the first quarter. Huntington National Bank now owns 4,455 shares of the company’s stock worth $202,000 after buying an additional 147 shares during the period. National Asset Management Inc. boosted its stake in shares of Sanofi by 1.0% in the first quarter. National Asset Management Inc. now owns 25,161 shares of the company’s stock worth $1,139,000 after buying an additional 243 shares during the period. Finally, Wedbush Securities Inc. boosted its stake in shares of Sanofi by 1.3% in the first quarter. Wedbush Securities Inc. now owns 19,045 shares of the company’s stock worth $862,000 after buying an additional 250 shares during the period. Institutional investors own 9.84% of the company’s stock.

Institutional Ownership by Quarter for Sanofi (NYSE:SNY)

Shares of Sanofi (SNY) traded up 2.08% during mid-day trading on Thursday, hitting $49.61. 5,003,465 shares of the stock traded hands. Sanofi has a one year low of $36.81 and a one year high of $50.24. The company has a market cap of $125.29 billion, a P/E ratio of 12.26 and a beta of 0.93. The stock has a 50 day moving average price of $48.82 and a 200-day moving average price of $44.16.

Sanofi (NYSE:SNY) last released its quarterly earnings results on Friday, April 28th. The company reported $0.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.03. The firm had revenue of $8.65 billion during the quarter, compared to analysts’ expectations of $8.40 billion. Sanofi had a return on equity of 25.89% and a net margin of 26.55%. The business’s quarterly revenue was up 1.2% on a year-over-year basis. On average, analysts forecast that Sanofi will post $3.15 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “RBF Capital LLC Has $2,290,000 Stake in Sanofi (SNY)” was published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/rbf-capital-llc-has-2290000-stake-in-sanofi-sny/1385952.html.

SNY has been the subject of a number of recent research reports. Barclays PLC initiated coverage on shares of Sanofi in a research report on Tuesday, March 7th. They issued an “underweight” rating for the company. Liberum Capital initiated coverage on shares of Sanofi in a research report on Thursday, March 9th. They issued a “hold” rating for the company. J P Morgan Chase & Co reiterated a “sell” rating on shares of Sanofi in a research report on Thursday, March 30th. Argus assumed coverage on shares of Sanofi in a report on Thursday, April 6th. They issued a “buy” rating and a $50.00 price objective for the company. Finally, HSBC Holdings plc lowered shares of Sanofi from a “hold” rating to a “reduce” rating in a report on Friday, April 7th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $67.67.

About Sanofi

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Want to see what other hedge funds are holding SNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sanofi (NYSE:SNY).

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with Analyst Ratings Network's FREE daily email newsletter.